106 related articles for article (PubMed ID: 28338113)
1. Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study.
Jurj A; Tomuleasa C; Tat TT; Berindan-Neagoe I; Vesa SV; Ionescu DC
J Gastrointestin Liver Dis; 2017 Mar; 26(1):45-50. PubMed ID: 28338113
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo.
Xing W; Chen DT; Pan JH; Chen YH; Yan Y; Li Q; Xue RF; Yuan YF; Zeng WA
Anesthesiology; 2017 May; 126(5):868-881. PubMed ID: 28121635
[TBL] [Abstract][Full Text] [Related]
3. Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells.
Le Gac G; Angenard G; Clément B; Laviolle B; Coulouarn C; Beloeil H
Anesth Analg; 2017 Nov; 125(5):1600-1609. PubMed ID: 28857796
[TBL] [Abstract][Full Text] [Related]
4. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
5. Flavan enantiomers from Daphne giraldii selectively induce apoptotic cell death in p53-null hepatocarcinoma cells in vitro.
Yao GD; Sun Q; Song XY; Huang XX; Song SJ
Chem Biol Interact; 2018 Jun; 289():1-8. PubMed ID: 29698619
[TBL] [Abstract][Full Text] [Related]
6. Effects of Lidocaine-Mediated CPEB3 Upregulation in Human Hepatocellular Carcinoma Cell Proliferation In Vitro.
Liu H; Wang Y; Chen B; Shen X; Li W
Biomed Res Int; 2018; 2018():8403157. PubMed ID: 29850575
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment.
Tat T; Jurj A; Selicean C; Pasca S; Ionescu D
J BUON; 2019; 24(1):106-115. PubMed ID: 30941958
[TBL] [Abstract][Full Text] [Related]
8. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells].
Yang Y; Zhou XF; Liu AD
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750
[TBL] [Abstract][Full Text] [Related]
9. [Cinnamaldehyde ofloxacin-3-ylhydrazone induces apoptosis of human hepatocarcinoma SMMC-7721 cells].
Ren Z; Kang YH; Shi ZY; Huang-Fu CS; Hu GQ; Liu B
Yao Xue Xue Bao; 2010 Sep; 45(9):1109-15. PubMed ID: 21351566
[TBL] [Abstract][Full Text] [Related]
10. Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG
Ghazi T; Nagiah S; Tiloke C; Sheik Abdul N; Chuturgoon AA
J Cell Biochem; 2017 Nov; 118(11):3866-3874. PubMed ID: 28387973
[TBL] [Abstract][Full Text] [Related]
11. Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines.
Montazeri M; Sadeghizadeh M; Pilehvar-Soltanahmadi Y; Zarghami F; Khodi S; Mohaghegh M; Sadeghzadeh H; Zarghami N
Int J Pharm; 2016 Jul; 509(1-2):244-254. PubMed ID: 27234697
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib inhibition of hepatic stellate cell proliferation in tumor microenvironment of hepatocellular carcinoma: a study of the sorafenib mechanisms.
Geng ZM; Jha RK; Li B; Chen C; Li WZ; Zheng JB; Wang L; Huanchen S
Cell Biochem Biophys; 2014 Jul; 69(3):717-24. PubMed ID: 24633454
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
[TBL] [Abstract][Full Text] [Related]
16. Plasma from patients with acute liver failure dampens HepG2 cells to epidermal growth factor induced proliferation response.
Li W; Long J; Takikawa Y; Suzuki K; Lin S
Hepatogastroenterology; 2014 Oct; 61(135):2021-7. PubMed ID: 25713905
[TBL] [Abstract][Full Text] [Related]
17. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
Li H; Fang L; Xiao X; Shen L
Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
19. [A new natural polyphenol BJA32531 inhibited the proliferation and regulated miRNA expression in human HepG2 hepatocarcinoma cells].
Ai RT; Wu SY; Wen XY; Xu W; Lv L; Wu SG
Zhong Yao Cai; 2011 Nov; 34(11):1734-40. PubMed ID: 22506400
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
